Clinical Trial Update: MUC1 Vaccine in Conjunction With Poly-ICLC in Patients With Recurrent and/or Advanced Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluated a MUC1 vaccine in combination with Poly-ICLC in patients with recurrent or advanced prostate cancer. The study status is comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• MUC1 vaccine (Mucin-1 vaccine)
• Poly-ICLC (poly-ICLC)

Snippet

Sponsor: Olivera Finn | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED